Three-dimensional label-free morphology of CD8+ T cells as a sepsis biomarker

Sepsis is a life-threatening condition with high mortality rates due to the complex and variable immune response. Early diagnosis and prompt intervention are essential. Existing biomarkers such as CRP and PCT have limitations, including delayed responses. Efforts to address this delay include using RNA levels and single-cell sequencing, but these methods are time-consuming.

Immune cell morphology shows promise as a rapid biomarker. Morphological changes occur rapidly during inflammation and can provide an immediate insight into the immune response. However, the complexity of human immune responses is lacking in most studies using cell lines or healthy cells. Comprehensive investigations are needed to overcome these limitations and accurately capture immune cell dynamics in sepsis.

In a new paper published in Light: Science & Applications, a team of scientists led by Professor Yu Rang Park and Kyung Soo Chung from Yonsei University College of Medicine, South Korea, and co-workers developed an artificial intelligence model using label-free 3D imaging to analyze changes in immune cell structure during healthy conditions, sepsis diagnosis, and sepsis recovery.

By comparing data between healthy controls and sepsis patients at different stages of recovery, the team identified significant changes in morphological characteristics such as CD8⁺ T-cell volume and dry mass. More interestingly, this suggests that 3D label-free CD8⁺ T cell structures can complement traditional diagnostic tools and provide valuable insights for clinical decision-making in sepsis cases.

Moreover, their suitability for periodic and repeated testing, requiring only a small blood sample, makes them a promising candidate for routine monitoring of sepsis patients.

"The technology developed in this study can be applied to a variety of patients with poor immune status as a model for predicting patient health. By using this breakthrough technology as a fast and highly accurate model to measure patient condition based on a small blood sample, it can be applied to various diseases, opening a new chapter in precision measurement and diagnosis," the scientists predict.